![coronavirus]()
The debate on whether hydroxychloroquine (HCQ) helps
prevent, quell or cure COVID-19 seems never-ending as health care providers,
the WHO, the U.S. FDA and researchers weigh in on whether it should be used to
treat coronavirus, or not.
In June 2020, the FDA announced the drug was “unlikely to be
effective in treating COVID-19” and “that serious cardiac side effects” could
make it more a risk than a benefit. A couple months later, on August 5, 2020,
Henry Ford Health System posted an open letter to the world, urging randomized
clinical trials to continue.
“The political climate that has persisted has made any
objective discussion about this drug impossible,” the Ford letter said. All
during this time, many doctors from around the world have supported its use to
fight COVID-19, using their own successes with the drug as an example.
Now, writing in The Hill, Baylor University Medical center
vice chairman Dr. Peter A. McCullough, is criticizing the politicization of
HCQ, saying researchers have failed HCQ, and that the drug needs to be made
openly available to health care providers as a treatment method.
SOURCES:
The
Hill August 7, 2020
Henry
Ford Health System August 3, 2020
The
Enquirer June 18, 2020